Two tests and one reference [General Sta­tis­tics]

posted by ElMaestro  – Denmark, 2020-08-31 10:23 (663 d 20:49 ago) – Posting: # 21896
Views: 5,209

Hi Brus,

» If one test and two references of different regions are tested in a bioequivalence study, is it necessary a α adjustment?
» In my case, we want to demonstrate if the test product is bioequivalent to R1 (European product reference) or if test product is bioequivalent to R2 (Reference product in the United Kingdom).
» If I have not misunderstood, in this case, alpha should be penalized, even if they are from different regions and to market in different regions because of the word "OR"?
» Is there a way to not penalize alpha? If the "O" is changed to "AND"? Executing two different clinical trials (one for Europe and one for the UK)?

Here's a different way to look at it:
Can the same patient(s) be affected by your two tests? If yes, it is safer to use correction. If no, no correction should be necessary.

Pass or fail!

Complete thread:

UA Flag
 Admin contact
22,167 posts in 4,645 threads, 1,572 registered users;
online 8 (0 registered, 8 guests [including 2 identified bots]).
Forum time: Sunday 07:13 CEST (Europe/Vienna)

The person interested in success has to learn
to view failure as a healthy, inevitable part
of the process of getting to the top.    Joyce Brothers

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz